z-logo
open-access-imgOpen Access
β‑catenin inhibitors ICG‑001 and pyrvinium sensitize bortezomib‑resistant multiple myeloma cells to bortezomib
Author(s) -
Cuicui Wu
Publication year - 2022
Publication title -
oncology letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.766
H-Index - 54
eISSN - 1792-1082
pISSN - 1792-1074
DOI - 10.3892/ol.2022.13326
Subject(s) - bortezomib , apoptosis , wnt signaling pathway , flow cytometry , viability assay , cell culture , medicine , catenin , cancer research , cell , cell cycle , chemistry , multiple myeloma , pharmacology , signal transduction , biology , immunology , biochemistry , genetics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom